School of Pharmacy & Technology Management, SVKM's NMIMS, Shirpur, Maharashtra, India.
Crit Rev Anal Chem. 2021;51(3):258-267. doi: 10.1080/10408347.2020.1718481. Epub 2020 Feb 5.
Apremilast is an anti-inflammatory agent. It has been a flourishing molecule in the field of dermatology. In the year 2014, Apremilast got its approval for treatment of psoriatic arthritis. Presently it is known to treat a number of other conditions, including atopic dermatitis and plaque psoriasis. Apremilast a phthalimide derivative, is non-hygroscopic in nature. It is practically insoluble in water. Apremilast acts by inhibiting the activity of phosphodiesterase 4 (PDE4), an intracellular enzyme. Analytical method plays a key role to understand the physio-chemical properties of a drug molecule. Because of poor solubility and low permeability, analytical method development and formulation becomes challenging. Till date, there are no standard test methods available to analyze Apremilast. So, a critical review of the analytical techniques of Apremilast was carried out. The literature search was done by screening the papers reporting analytical techniques of Apremilast from year 2014 to 2019. Methodologies particularly UV spectroscopy, HPTLC, HPLC, X-ray diffraction, NMR, LC-MS were collected and reviewed. Interminable efforts are made by the researchers to develop simple, accurate, robust and cost-effective methods of analysis. In pharmaceutical research, this information will aid in the development of new delivery systems. The review will prove beneficial and advantageous pre-formulation studies and will guide the formulation development.
阿普司特是一种抗炎药。它在皮肤病学领域是一种很有前途的药物。2014 年,阿普司特获得批准用于治疗银屑病关节炎。目前,它已被证明可用于治疗多种其他疾病,包括特应性皮炎和斑块状银屑病。阿普司特是一种邻苯二甲酰亚胺衍生物,性质不易吸湿。实际上它在水中几乎不溶。阿普司特通过抑制细胞内酶磷酸二酯酶 4(PDE4)的活性起作用。分析方法对于了解药物分子的物理化学性质起着关键作用。由于溶解度差和渗透性低,分析方法的开发和制剂变得具有挑战性。到目前为止,还没有标准的测试方法可用于分析阿普司特。因此,对阿普司特的分析技术进行了批判性评价。通过筛选 2014 年至 2019 年报道阿普司特分析技术的论文,进行了文献检索。收集并综述了方法,特别是紫外光谱法、HPTLC、HPLC、X 射线衍射、NMR、LC-MS。研究人员进行了不懈的努力,以开发简单、准确、强大且具有成本效益的分析方法。在药物研究中,这些信息将有助于开发新的给药系统。该综述将证明对预配方研究有益和有利,并指导配方开发。